Acadia Pharmaceuticals Inc. (ACAD)

[jerseyboy]

I hope you're right. Three weeks is not too long to wait, but one analyst at Mizuho thinks that they will need to do one or two more studies to satisfy the FDA in order to be able to move forward with marketing this indication, and that is too long for me to wait. I think the share price will be over $40 eventually, but I don't think it will be by the end of this year. I believe your patience will eventually be rewarded, but I have other stocks that I think will develop faster with less risk of encountering seemingly capricious and possibly adversarial opposition.